Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
Prioritize glucose-lowering therapies with additional kidney and/or heart disease benefits over treatments that target only blood glucose levels
Nausea typically peaks within 35 days of starting or increasing tirzepatide and usually resolves within 12 weeks as your body adapts
Available from: [Last accessed on 2025 Oct 12]
The best form depends on your claim, dosage form, flavor system and target consumer
Within 5 years post-surgery, WR rates can range from 37% to 76% among patients undergoing gastric bypass [13] and sleeve gastrectomy [14, 15], respectively
